SCHEMBL7983567

SCHEMBL7983567

COCCOc1cccc2nc(Nc3c(C)cccc3Cl)c3cncn3c12

nearest known ligand 0.79

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7970210 0.91 LCK (0.76) LCK
SCHEMBL7984301 0.90 LCK (0.75) LCK
SCHEMBL7979979 0.89 LCK (0.73) LCK
SCHEMBL7981217 0.88 LCK (1.00) LCK
SCHEMBL7970017 0.86 LCK (1.00) LCK
SCHEMBL7980248 0.85 LCK (0.84) LCK
SCHEMBL7970126 0.85 LCK (0.75) LCK
SCHEMBL4039941 0.84 LCK (0.60) LCK
SCHEMBL7979714 0.80 LCK (0.74) LCK
SCHEMBL7987002 0.79 LCK (0.79) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed